A-blockers for the management of lower urinary tract symptoms in patients with prostate cancer treated with external beam radiotherapy: a randomized controlled study
- 1 June 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in World Journal of Urology
- Vol. 39 (6), 1805-1813
- https://doi.org/10.1007/s00345-020-03398-3
Abstract
Background This is a prospective study aiming to assess the efficacy of alpha-blockers in treating radiotherapy-induced symptoms of the lower urinary tract and its possible prophylactic role on acute urinary retention (AUR) in patients undergoing radical external beam radiotherapy (EBRT) for localized prostate cancer (PCa). Methods Overall, 108 patients with localized PCa were recruited and randomly assigned in to two groups; 54 patients of Group 1 received tamsulosin 0.4 mg once daily with the initiation of EBRT and for 6 months and 54 patients of Group 2 served as the control group. All patients received radical EBRT and had post-void volume (Vres) assessment. The International Prostate Symptom Score (IPSS) questionnaire and evaluation of episodes of AUR were performed after the end of radiotherapy, at 3 and at 6 months. Results The incidence of AUR was significantly (p = 0.027) lower in group 1 compared to group 2. No independent predictive factors for AUR were identified in regression analysis. The IPSS changes in univariate and multivariate analysis at 3 months showed significant correlation with alpha-blockers only, while at 6 months showed significant correlation with Vres assessments (at 3 and 6 months) and with alpha-blockers. Side effects due to medication were mild and none of the patients discontinued the treatment. Conclusions The selective use of alpha-blocker appears to prevent AUR in EBRT-treated patients. Although the administration of alpha-blockers might relieve patient-reported symptoms, there are no established independent predictive factors to distinguish patients who may benefit.Keywords
This publication has 57 references indexed in Scilit:
- External Beam Radiotherapy for Prostate Cancer: Urinary Outcomes for Men With High International Prostate Symptom Scores (IPSS)International Journal of Radiation Oncology*Biology*Physics, 2011
- Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC): An Introduction to the Scientific IssuesInternational Journal of Radiation Oncology*Biology*Physics, 2010
- The Effects of Combination Therapy with Dutasteride and Tamsulosin on Clinical Outcomes in Men with Symptomatic Benign Prostatic Hyperplasia: 4-Year Results from the CombAT StudyEuropean Urology, 2009
- Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer – 15 years’ follow-up. A comparison with age-matched controlsActa Oncologica, 2008
- The Effects of Dutasteride, Tamsulosin and Combination Therapy on Lower Urinary Tract Symptoms in Men With Benign Prostatic Hyperplasia and Prostatic Enlargement: 2-Year Results From the CombAT StudyJournal of Urology, 2007
- Preimplant Predictive Factors of Urinary Retention After Iodine 125 Prostate BrachytherapyUrology, 2007
- Preventing or reducing late side effects of radiation therapy: radiobiology meets molecular pathologyNature Reviews Cancer, 2006
- Three months’ treatment with the α1-blocker alfuzosin does not affect total or transition zone volume of the prostateProstate Cancer and Prostatic Diseases, 2006
- Longitudinal study of men with mild symptoms of bladder outlet obstruction treated with watchful waiting for four yearsUrology, 2004
- The International Prostate Symptom Score in a community‐based sample of men between 55 and 74 years of age: prevalence and correlation of symptoms with age, prostate volume, flow rate and residual urine volumeBritish Journal of Urology, 1995